GoodRx bets on working with pharmacies as prescription-drug reimbursement pressure grows

Legislators who want to see an extension of COVID-era telemedicine flexibilities slammed a draft proposed rule from the Drug Enforcement Administration (DEA) that would curb

The FDA ap­proved a Hous­ton drug­mak­er’s tablet for adults with ma­jor de­pres­sive dis­or­der last week, cap­ping a decades-long back-and-forth be­tween mul­ti­ple com­pa­nies and the reg­u­la­tor

NASHVILLE, Tenn. — Every-6-month dosing of the long-acting injectable paliperidone palmitate (Invega Hafyera) for schizophrenia was effective and safe up to 3 years, researchers reported